TB & Outbreaks Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB & Outbreaks Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
HIV/AIDS Therapy
New HIV/AIDS therapy research from University of Manitoba, Faculty of Medicine described
July 1st, 2008
Scientists discuss in 'Characterization of a trypsin-dependent avian influenza H5N1-pseudotyped HIV vector system for high throughput screening of inhibitory molecules' new findings in HIV/AIDS. According to recent research from Canada, "In this study, we have generated and characterized an avian influenza H5N1 hemagglutinin (HA), neuraminidase (NA) and M2 ion channel pseudotyped HIV-based vector system (HaNaM-pseudotyped HIV vector). The cleavage site of the HA protein was modified to necessitate trypsin-dependent maturation of the glycoprotein." "HA, NA and M2 were efficiently incorporated in HIV vector particles which could transduce different cell lines in a...
Source: TB & Outbreaks Week (2008-07-01)
|
